{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:26:44Z","timestamp":1793608004203,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["JKY01251516"],"award-info":[{"award-number":["JKY01251516"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["25ZR1401088"],"award-info":[{"award-number":["25ZR1401088"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22577027"],"award-info":[{"award-number":["22577027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22071054"],"award-info":[{"award-number":["22071054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016109","name":"Taishan Industry Leading Talents","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011208","name":"Shanghai Key Laboratory of Chemical Biology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011208","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129124","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:40:00Z","timestamp":1788522000000},"page":"129124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preparation and functional evaluation of an alginate-targeted monoclonal antibody against Pseudomonas aeruginosa"],"prefix":"10.1016","volume":"92","author":[{"given":"Xiaotong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanyuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129124_bb0005","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1086\/432803","article-title":"National nosocomial infections surveillance system, overview of nosocomial infections caused by gram-negative bacilli","volume":"41","author":"Gaynes","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129124_bb0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nrmicro2907","article-title":"Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective","volume":"10","author":"Folkesson","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.vaccine.2026.129124_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13756-018-0370-9","article-title":"Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis","volume":"7","author":"Raman","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.vaccine.2026.129124_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.vaccine.2026.129124_bb0025","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.vaccine.2026.129124_bb0030","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","volume":"25","author":"Sati","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129124_bb0035","article-title":"Pseudomonas aeruginosa: pathogenesis-immunity arm race, vaccine and therapeutics development panoramas","volume":"9","author":"Odoom","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.vaccine.2026.129124_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12864-016-2364-4","article-title":"Pangenome-wide and molecular evolution analyses of the Pseudomonas aeruginosa species","volume":"17","author":"Mosquera-Rendon","year":"2016","journal-title":"BMC Genomics"},{"key":"10.1016\/j.vaccine.2026.129124_bb0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/fmb.14.10","article-title":"Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update","volume":"9","author":"Vincent","year":"2014","journal-title":"Future Microbiol."},{"key":"10.1016\/j.vaccine.2026.129124_bb0050","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/jac\/dkr038","article-title":"Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection","volume":"66","author":"Secher","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.vaccine.2026.129124_bb0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","article-title":"Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.vaccine.2026.129124_bb0060","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1128\/JB.184.13.3614-3622.2002","article-title":"Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa","volume":"184","author":"Raymond","year":"2002","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.vaccine.2026.129124_bb0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fmicb.2011.00118","article-title":"Genetic and functional diversity of Pseudomonas aeruginosa lipopolysaccharide","volume":"2","author":"Lam","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.vaccine.2026.129124_bb0070","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1128\/jcm.25.4.656-659.1987","article-title":"Alginate production by clinical nonmucoid Pseudomonas aeruginosa","volume":"25","author":"Anastassiou","year":"1987","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2026.129124_bb0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1128\/jcm.24.2.189-196.1986","article-title":"Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients","volume":"24","author":"Pier","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2026.129124_bb0080","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/infdis\/148.2.206","article-title":"Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa","volume":"148","author":"Pier","year":"1983","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129124_bb0085","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/431516","article-title":"Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model","volume":"192","author":"Bragonzi","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129124_bb0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0141-8130(02)00002-8","article-title":"Monomer composition and sequence of alginates from Pseudomonas aeruginosa","volume":"30","author":"Schurks","year":"2002","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.vaccine.2026.129124_bb0095","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1574-6976.2011.00322.x","article-title":"Pseudomonas biofilm matrix composition and niche biology","volume":"36","author":"Mann","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.vaccine.2026.129124_bb0100","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1128\/IAI.69.3.1895-1901.2001","article-title":"Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis","volume":"69","author":"Pier","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2026.129124_bb0105","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.4049\/jimmunol.173.9.5671","article-title":"Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains","volume":"173","author":"Pier","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2026.129124_bb0110","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00253-019-10310-6","article-title":"Analysis of the alginate O-acetylation machinery in Pseudomonas aeruginosa","volume":"104","author":"Chanasit","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.vaccine.2026.129124_bb0115","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/IAI.00157-11","article-title":"Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice","volume":"79","author":"Campodonico","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2026.129124_bb0120","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1021\/acs.orglett.2c03439","article-title":"Promoter-controlled synthesis and antigenic evaluation of mannuronic acid alginate glycans of Pseudomonas aeruginosa","volume":"24","author":"Zhang","year":"2022","journal-title":"Org. Lett."},{"key":"10.1016\/j.vaccine.2026.129124_bb0125","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1021\/acscentsci.4c00387","article-title":"A semisynthetic oligomannuronic acid-based glycoconjugate vaccine against Pseudomonas aeruginosa","volume":"10","author":"Zhang","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.vaccine.2026.129124_bb0130","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1128\/AAC.02588-15","article-title":"A high-affinity native human antibody disrupts biofilm from Staphylococcus aureus bacteria and potentiates antibiotic efficacy in a mouse implant infection model","volume":"60","author":"Estelles","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.vaccine.2026.129124_bb0135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1021\/acscentsci.3c01507","article-title":"Discovery of a monoclonal antibody that targets cell-surface pseudaminic acid of Acinetobacter baumannii with direct bactericidal effect","volume":"10","author":"Yang","year":"2024","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.vaccine.2026.129124_bb0140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.129124_bb0145","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/D5OB01793A","article-title":"Synthesis of aminoglucuronic acid glycans from the capsular polysaccharide of Staphylococcus aureus type 2","volume":"24","author":"Shang","year":"2026","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.vaccine.2026.129124_bb0150","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.1007\/s00210-025-04941-y","article-title":"Bibliometric analysis of Pseudomonas aeruginosa vaccine development highlighting research status, evolution, and future opportunities","volume":"399","author":"Huang","year":"2026","journal-title":"N-S Arch Pharmacol"},{"key":"10.1016\/j.vaccine.2026.129124_bb0155","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/antibiotics10121530","article-title":"Potential therapeutic targets for combination antibody therapy against Pseudomonas aeruginosa infections","volume":"10","author":"Proctor","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.vaccine.2026.129124_bb0160","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1099\/00221287-146-10-2395","article-title":"Quantification of biofilm structures by the novel computer program COMSTAT","volume":"146","author":"Heydorn","year":"2000","journal-title":"Microbiology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:35:01Z","timestamp":1793604901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S0264410X26009333"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129124","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation and functional evaluation of an alginate-targeted monoclonal antibody against Pseudomonas aeruginosa","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129124"}}